Letter: <scp>NSBB</scp> for fatty liver disease—Still a long way to go. Authors' reply-Reference-Cited by-同舟云学术

Letter: NSBB for fatty liver disease—Still a long way to go. Authors' reply

Published:2023-09-28 Issue:8 Volume:58 Page:848-849
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Jachs Mathias¹²^ORCID,Paternostro Rafael¹²^ORCID,Reiberger Thomas¹²³^ORCID,Mandorfer Mattias¹²^ORCID

Affiliation:

1. Division of Gastroenterology and Hepatology, Department of Internal Medicine III Medical University of Vienna Vienna Austria

2. Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Internal Medicine III Medical University of Vienna Vienna Austria

3. Christian Doppler Laboratory for Portal Hypertension and Liver Fibrosis Medical University of Vienna Vienna Austria

Abstract

LINKED CONTENTThis article is linked to Paternostro et al papers. To view these articles, visit https://doi.org/10.1111/apt.17653 and https://doi.org/10.1111/apt.17692

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17702

Reference10 articles.

1. Diabetes impairs the haemodynamic response to non‐selective betablockers in compensated cirrhosis and predisposes to hepatic decompensation;Paternostro R;Aliment Pharmacol Ther,2023

2. Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis

3. Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease

4. Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers

5. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol